We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$88.5B
AUM Growth
+$2.22B
Cap. Flow
-$721M
Cap. Flow %
-0.81%
Top 10 Hldgs %
14.33%
Holding
2,695
New
65
Increased
1,198
Reduced
577
Closed
89

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$205M
2
JNJ icon
Johnson & Johnson
JNJ
+$186M
3
HON icon
Honeywell
HON
+$177M
4
MDLZ icon
Mondelez International
MDLZ
+$132M
5
BABA icon
Alibaba
BABA
+$130M

Sector Composition

Rank Sector Weight
1 Healthcare 15.89%
2 Technology 14.47%
3 Financials 12.9%
4 Consumer Discretionary 10.06%
5 Communication Services 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AF
1601
DELISTED
Astoria Financial Corporation
AF
$979K ﹤0.01%
63,853
-2,262
-3% -$34.7K
STAY
1602
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$978K ﹤0.01%
65,397
+15,465
+31% +$232K
IRWD icon
1603
Ironwood Pharmaceuticals
IRWD
$683M
$973K ﹤0.01%
88,816
+2,201
+3% +$21.5K
CBM
1604
DELISTED
Cambrex Corporation
CBM
$972K ﹤0.01%
18,799
+2,400
+15% +$115K
SCTY
1605
DELISTED
SolarCity Corporation
SCTY
$971K ﹤0.01%
40,571
BHE icon
1606
Benchmark Electronics
BHE
$3.02B
$968K ﹤0.01%
45,781
INFN
1607
DELISTED
Infinera Corporation Common Stock
INFN
$968K ﹤0.01%
85,840
-1,021
-1% -$13.3K
WTS icon
1608
Watts Water Technologies
WTS
$12.1B
$966K ﹤0.01%
16,580
FINL
1609
DELISTED
Finish Line
FINL
$966K ﹤0.01%
47,838
-34,206
-42% -$647K
RSE
1610
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
$966K ﹤0.01%
52,923
+100
+0.2% +$1.83K
ARIA
1611
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$965K ﹤0.01%
130,696
RARE icon
1612
Ultragenyx Pharmaceutical
RARE
$2.46B
$962K ﹤0.01%
19,659
+7,492
+62% +$485K
DORM icon
1613
Dorman Products
DORM
$4.23B
$956K ﹤0.01%
16,716
+3,517
+27% +$189K
ATW
1614
DELISTED
Atwood Oceanics
ATW
$954K ﹤0.01%
76,217
-7,916
-9% -$82.6K
EXLS icon
1615
EXL Service
EXLS
$5.11B
$946K ﹤0.01%
90,240
+19,290
+27% +$196K
CYS
1616
DELISTED
CYS Investments Inc.
CYS
$945K ﹤0.01%
112,844
-4,000
-3% -$32.9K
NYT icon
1617
New York Times
NYT
$10.6B
$944K ﹤0.01%
78,029
PBR.A icon
1618
Petrobras Class A
PBR.A
$105B
$943K ﹤0.01%
162,381
-9,500
-6% -$49.1K
FOMX
1619
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$942K ﹤0.01%
148,377
-514
-0.3% -$3.41K
NGVT icon
1620
Ingevity
NGVT
$2.65B
$935K ﹤0.01%
+27,454
New +$857K
BFS
1621
Saul Centers
BFS
$825M
$933K ﹤0.01%
15,119
+292
+2% +$16.3K
IBOC icon
1622
International Bancshares
IBOC
$4.72B
$931K ﹤0.01%
35,665
SBY
1623
DELISTED
Silver Bay Realty Trust Corp.
SBY
$931K ﹤0.01%
54,689
+1,900
+4% +$28.8K
NXST icon
1624
Nexstar Media Group
NXST
$5.8B
$929K ﹤0.01%
19,513
+4,513
+30% +$225K
VTVT icon
1625
vTv Therapeutics
VTVT
$135M
$924K ﹤0.01%
3,984
-2,203
-36% -$507K

Similar funds

UBS AM's Q2 2016 Portfolio in Review

As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
  • UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
  • UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
  • UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
  • UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
  • UBS AM opened 65 new positions and closed 89 in Q2 2016.
  • UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.

Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.